Chevy Chase Trust Holdings, Inc. United Therapeutics Corp Transaction History
Chevy Chase Trust Holdings, Inc.
- $33.7 Billion
- Q2 2025
A detailed history of Chevy Chase Trust Holdings, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 28,057 shares of UTHR stock, worth $7.91 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
28,057
Previous 22,664
23.8%
Holding current value
$7.91 Million
Previous $6.99 Million
15.4%
% of portfolio
0.02%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding UTHR
# of Institutions
734Shares Held
43.1MCall Options Held
125KPut Options Held
124K-
Black Rock Inc. New York, NY5.47MShares$1.54 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.46MShares$1.26 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.68MShares$754 Million13.34% of portfolio
-
State Street Corp Boston, MA2.23MShares$629 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.11MShares$594 Million1.04% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $12.8B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...